• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Initial Public Offering (IPO)

Danaher dental spinout Envista preps $600m IPO

September 16, 2019 By Brad Perriello

The dental business spinout at Danaher (NYSE:DHR), Envista, is gearing up for a $600 million initial public offering this week. The spinout, announced in July 2018, will unite the Nobel Biocare, KaVo Kerr and Ormco dental brands under the Envista umbrella. The newly public company, which employs some 12,000 workers, is headquartered in Brea, Calif. Envista […]

Filed Under: Dental, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Danaher Corp., Envista

SmileDirect Club plunges after IPO

September 13, 2019 By Brad Perriello

Shares in SmileDirectClub (NSDQ:SDC) regained some of their value this morning after closing down some -28% after their public debut yesterday. Nashville, Tenn.-based SmileDirectClub makes 3D-printed clear dental aligners designed to provide an alternative to traditional braces. The company floated 58.5 million shares at $23 apiece in its $1.35 billion initial public offering yesterday, only to […]

Filed Under: Dental, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: smiledirectclub

Satsuma Pharmaceuticals registers $75m IPO

September 9, 2019 By Nancy Crotti

Satsuma Pharmaceuticals has registered an initial public offering, seeking to raise $75 million, according to a regulatory filing. The South San Francisco-based company is working on STS101, a nasal powder version of dihydroergotamine for migraine. It intends to use the money to fund its Phase 3 safety and efficacy clinical trials for STS101, manufacturing costs, preparation for […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: Satsuma Pharmaceuticals

Frequency Therapeutics registers $100m IPO

September 9, 2019 By Sean Whooley

Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), News Well, Otolaryngology/Ear, Nose & Throat (ENT), Research & Development, Stem Cells Tagged With: Frequency Therapeutics

InMode pulls down $70m with IPO

August 13, 2019 By Brad Perriello

InMode (NSDQ:INMD) yesterday closed its initial public offering, saying it grossed $70 million for the  radiofrequency devices it’s developing for aesthetic medical procedures. Proceeds from the flotation of 5 million shares at $14 apiece are earmarked for hiring additional sales and marketing personnel and expanding those programs and for funding R&D, working capital and general […]

Filed Under: Cosmetic/Aesthetic, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: InMode Aesthetic Solutions

Quanterix prices IPO common stock at $60m

August 9, 2019 By Danielle Kirsh

Quanterix today announced an initial public offering of nearly 2.4 million shares of common stock at $25.25 apiece for which it expects to gross $60 million. Billerica, Mass.-based Quanterix is developing a digital approach to immunoassays to allow single molecules to be counted. Its technology is used in the therapeutic areas of oncology, neurology, cardiology, […]

Filed Under: Initial Public Offering (IPO), Wall Street Beat Tagged With: Quanterix Corp.

InMode prices IPO at $70m

August 9, 2019 By Danielle Kirsh

InMode this week announced an initial public offering of 5 million shares, for which it expects to gross $70 million. Lake Forest, Calif.-based InMode is developing devices that use minimally invasive radio-frequency technology for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode set the floatation at $14 per share, giving underwriters a 30-day option to […]

Filed Under: Initial Public Offering (IPO), Wall Street Beat Tagged With: InMode Aesthetic Solutions

Livongo share prices double after upsized $356m IPO

July 25, 2019 By Brad Perriello

Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]

Filed Under: Diabetes, Digital Health, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Livongo

Livongo boosts IPO to $268m midpoint

July 23, 2019 By Brad Perriello

Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]

Filed Under: Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Livongo, value-based healthcare

Livongo Health files for $100m IPO

July 1, 2019 By Brad Perriello

Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose reading […]

Filed Under: Diabetes, Digital Health, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: Livongo

Mobile health dev G Medical Innovations sets terms for $17m IPO

June 4, 2019 By Fink Densford

Early-stage developer G Medical Innovations today set the terms for an upcoming initial public offering that could bring in approximately $17.3 million for the company. G Medical Innovations is developing wireless technologies and proprietary information technology and serve platforms for the healthcare market, according to its website. The company’s current products under development include a smartphone […]

Filed Under: Business/Financial News, Initial Public Offering (IPO), Wall Street Beat Tagged With: gmedicalinnovations

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 35
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS